Analysis and differentiation of tobacco-derived and synthetic nicotine products: Addressing an urgent regulatory issue
- PMID: 35421170
- PMCID: PMC9009602
- DOI: 10.1371/journal.pone.0267049
Analysis and differentiation of tobacco-derived and synthetic nicotine products: Addressing an urgent regulatory issue
Abstract
There is significant regulatory and economic need to distinguish analytically between tobacco-derived nicotine (TDN) and synthetic nicotine (SyN) in commercial products. Currently, commercial e-liquid and oral pouch products are available that contain tobacco-free nicotine, which could be either extracted from tobacco or synthesized. While tobacco products that contain TDN are regulated by FDA Center for Tobacco Products, those with SyN are currently not in the domain of any regulatory authority. This regulatory difference provides an economic incentive to use or claim the use of SyN to remain on the market without submitting a Premarket Tobacco Product Application. TDN is ~99.3% (S)-nicotine, whereas SyN can vary from racemic (50/50 (R)/(S)) to ≥ 99% (S)-nicotine, i.e., chemically identical to the tobacco-derived compound. Here we report efforts to distinguish between TDN and SyN in various samples by characterizing impurities, (R)/(S)-nicotine enantiomer ratio, (R)/(S)-nornicotine enantiomer ratio, and carbon-14 (14C) content. Only 14C analysis accurately and precisely differentiated TDN (100% 14C) from SyN (35-38% 14C) in all samples tested. 14C quantitation of nicotine samples by accelerator mass spectrometry is a reliable determinate of nicotine source and can be used to identify misbranded product labelled as containing SyN. This is the first report to distinguish natural, bio-based nicotine from synthetic, petroleum-based nicotine across a range of pure nicotine samples and commercial e-liquid products.
Conflict of interest statement
The authors are paid employees of their respective companies. Enthalpy Analytical, LLC, a wholly owned subsidiary of Montrose Environmental Group, Inc., is an independent contract research laboratory with a focus on nicotine-containing products that provides analytical testing services for a wide range of clients, including tobacco manufacturers and government regulatory authorities. Consilium Sciences provides consulting services, offering scientific and regulatory solutions for materials science, nicotine, and cannabis organizations with a focus on potentially harm-reduced products.
Figures







References
-
- Family Smoking Prevention and Tobacco Control Act of 2009, Pub. L. No. 111–31 (June 22, 2009).
-
- FDA Notifies Companies, Including Puff Bar, to Remove Flavored Disposable E-Cigarettes and Youth-Appealing E-Liquids from Market for Not Having Required Authorization [press release]. Silver Spring, MD: US Department of Health and Human Services, July 20, 2020.
-
- Puff Bar: Homepage 2021 [cited December 20, 2021]. Available from: https://puffbar.com.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous